Comparison of Symptomatic Vasospasm after Surgical Clipping and Endovascular Coiling

Vasospasm, initial neurological damage, rebleeding, and periprocedural complications are associated prognostic factors for clinical outcomes after aneurysmal subarachnoid hemorrhage (SAH). In this study, factors related to delayed ischemic neurological deficit (DIND) are evaluated using data from ou...

Full description

Bibliographic Details
Main Authors: Hirotoshi IMAMURA, Shoichi TANI, Hidemitsu ADACHI, Ryu FUKUMITSU, Tadashi SUNOHARA, Nobuyuki FUKUI, Yoshihiro OMURA, Natsuhi SASAKI, Tomoaki AKIYAMA, Tatsumaru FUKUDA, Shinji KAJIURA, Masashi SHIGEYASU, Kento ASAKURA, Ryo HORII, Nobuyuki SAKAI
Format: Article
Language:English
Published: The Japan Neurosurgical Society 2022-05-01
Series:Neurologia Medico-Chirurgica
Subjects:
Online Access:https://www.jstage.jst.go.jp/article/nmc/62/5/62_2021-0126/_pdf/-char/en
_version_ 1828213316324950016
author Hirotoshi IMAMURA
Shoichi TANI
Hidemitsu ADACHI
Ryu FUKUMITSU
Tadashi SUNOHARA
Nobuyuki FUKUI
Yoshihiro OMURA
Natsuhi SASAKI
Tomoaki AKIYAMA
Tatsumaru FUKUDA
Shinji KAJIURA
Masashi SHIGEYASU
Kento ASAKURA
Ryo HORII
Nobuyuki SAKAI
author_facet Hirotoshi IMAMURA
Shoichi TANI
Hidemitsu ADACHI
Ryu FUKUMITSU
Tadashi SUNOHARA
Nobuyuki FUKUI
Yoshihiro OMURA
Natsuhi SASAKI
Tomoaki AKIYAMA
Tatsumaru FUKUDA
Shinji KAJIURA
Masashi SHIGEYASU
Kento ASAKURA
Ryo HORII
Nobuyuki SAKAI
author_sort Hirotoshi IMAMURA
collection DOAJ
description Vasospasm, initial neurological damage, rebleeding, and periprocedural complications are associated prognostic factors for clinical outcomes after aneurysmal subarachnoid hemorrhage (SAH). In this study, factors related to delayed ischemic neurological deficit (DIND) are evaluated using data from our institute for the last 18 years. Data from 2001 to 2018 of patients with aneurysmal SAH who underwent surgical clipping (SC) or endovascular coiling (EC) within 7 days of onset were retrospectively analyzed. Cases of mortality within 5 days after treatment were excluded. Multivariate analysis was used to identify the risk factors for DIND. In total, 840 cases of SAH were assessed; among these cases, 384 (45.7%) and 456 (54.3%) were treated with SC and EC, respectively. The frequency of DIND in the EC group was significantly less than that in the SC group (11.8% vs. 17.7%; p = 0.016). In the results of multivariate analysis, internal carotid artery (ICA) aneurysm and hemorrhagic complications were the risk factors for DIND. Cilostazol administration and EC were significant factors for vasospasm prevention after aneurysmal SAH (odds ratio of ICA aneurysm: 1.59, hemorrhagic complications: 1.76, SC: 1.51, and cilostazol administration: 0.51, respectively). Cilostazol administration was also a significant factor in patients who were treated with EC. ICA aneurysm, treatment strategy, hemorrhagic complications, and cilostazol administration were associated with DIND. Oral administration of cilostazol and avoiding hemorrhagic complications were effective in DIND prevention. If both treatments are available for ruptured aneurysms, clinicians should choose EC on the basis of its ability to prevent DIND.
first_indexed 2024-04-12T14:48:20Z
format Article
id doaj.art-d174591ddb0c432291d3dfad023ecf47
institution Directory Open Access Journal
issn 1349-8029
language English
last_indexed 2024-04-12T14:48:20Z
publishDate 2022-05-01
publisher The Japan Neurosurgical Society
record_format Article
series Neurologia Medico-Chirurgica
spelling doaj.art-d174591ddb0c432291d3dfad023ecf472022-12-22T03:28:35ZengThe Japan Neurosurgical SocietyNeurologia Medico-Chirurgica1349-80292022-05-0162522323010.2176/jns-nmc.2021-01262021-0126Comparison of Symptomatic Vasospasm after Surgical Clipping and Endovascular CoilingHirotoshi IMAMURA0Shoichi TANI1Hidemitsu ADACHI2Ryu FUKUMITSU3Tadashi SUNOHARA4Nobuyuki FUKUI5Yoshihiro OMURA6Natsuhi SASAKI7Tomoaki AKIYAMA8Tatsumaru FUKUDA9Shinji KAJIURA10Masashi SHIGEYASU11Kento ASAKURA12Ryo HORII13Nobuyuki SAKAI14Department of Neurosurgery, Kobe City Medical Center General HospitalDepartment of Neurosurgery, Kobe City Medical Center General HospitalDepartment of Neurosurgery, Kobe City Medical Center General HospitalDepartment of Neurosurgery, Kobe City Medical Center General HospitalDepartment of Neurosurgery, Kobe City Medical Center General HospitalDepartment of Neurosurgery, Kobe City Medical Center General HospitalDepartment of Neurosurgery, Kobe City Medical Center General HospitalDepartment of Neurosurgery, Kobe City Medical Center General HospitalDepartment of Neurosurgery, Kobe City Medical Center General HospitalDepartment of Neurosurgery, Kobe City Medical Center General HospitalDepartment of Neurosurgery, Kobe City Medical Center General HospitalDepartment of Neurosurgery, Kobe City Medical Center General HospitalDepartment of Neurosurgery, Kobe City Medical Center General HospitalDepartment of Neurosurgery, Kobe City Medical Center General HospitalDepartment of Neurosurgery, Kobe City Medical Center General HospitalVasospasm, initial neurological damage, rebleeding, and periprocedural complications are associated prognostic factors for clinical outcomes after aneurysmal subarachnoid hemorrhage (SAH). In this study, factors related to delayed ischemic neurological deficit (DIND) are evaluated using data from our institute for the last 18 years. Data from 2001 to 2018 of patients with aneurysmal SAH who underwent surgical clipping (SC) or endovascular coiling (EC) within 7 days of onset were retrospectively analyzed. Cases of mortality within 5 days after treatment were excluded. Multivariate analysis was used to identify the risk factors for DIND. In total, 840 cases of SAH were assessed; among these cases, 384 (45.7%) and 456 (54.3%) were treated with SC and EC, respectively. The frequency of DIND in the EC group was significantly less than that in the SC group (11.8% vs. 17.7%; p = 0.016). In the results of multivariate analysis, internal carotid artery (ICA) aneurysm and hemorrhagic complications were the risk factors for DIND. Cilostazol administration and EC were significant factors for vasospasm prevention after aneurysmal SAH (odds ratio of ICA aneurysm: 1.59, hemorrhagic complications: 1.76, SC: 1.51, and cilostazol administration: 0.51, respectively). Cilostazol administration was also a significant factor in patients who were treated with EC. ICA aneurysm, treatment strategy, hemorrhagic complications, and cilostazol administration were associated with DIND. Oral administration of cilostazol and avoiding hemorrhagic complications were effective in DIND prevention. If both treatments are available for ruptured aneurysms, clinicians should choose EC on the basis of its ability to prevent DIND.https://www.jstage.jst.go.jp/article/nmc/62/5/62_2021-0126/_pdf/-char/envasospasmsurgical clippingendovascular coilingcilostazol
spellingShingle Hirotoshi IMAMURA
Shoichi TANI
Hidemitsu ADACHI
Ryu FUKUMITSU
Tadashi SUNOHARA
Nobuyuki FUKUI
Yoshihiro OMURA
Natsuhi SASAKI
Tomoaki AKIYAMA
Tatsumaru FUKUDA
Shinji KAJIURA
Masashi SHIGEYASU
Kento ASAKURA
Ryo HORII
Nobuyuki SAKAI
Comparison of Symptomatic Vasospasm after Surgical Clipping and Endovascular Coiling
Neurologia Medico-Chirurgica
vasospasm
surgical clipping
endovascular coiling
cilostazol
title Comparison of Symptomatic Vasospasm after Surgical Clipping and Endovascular Coiling
title_full Comparison of Symptomatic Vasospasm after Surgical Clipping and Endovascular Coiling
title_fullStr Comparison of Symptomatic Vasospasm after Surgical Clipping and Endovascular Coiling
title_full_unstemmed Comparison of Symptomatic Vasospasm after Surgical Clipping and Endovascular Coiling
title_short Comparison of Symptomatic Vasospasm after Surgical Clipping and Endovascular Coiling
title_sort comparison of symptomatic vasospasm after surgical clipping and endovascular coiling
topic vasospasm
surgical clipping
endovascular coiling
cilostazol
url https://www.jstage.jst.go.jp/article/nmc/62/5/62_2021-0126/_pdf/-char/en
work_keys_str_mv AT hirotoshiimamura comparisonofsymptomaticvasospasmaftersurgicalclippingandendovascularcoiling
AT shoichitani comparisonofsymptomaticvasospasmaftersurgicalclippingandendovascularcoiling
AT hidemitsuadachi comparisonofsymptomaticvasospasmaftersurgicalclippingandendovascularcoiling
AT ryufukumitsu comparisonofsymptomaticvasospasmaftersurgicalclippingandendovascularcoiling
AT tadashisunohara comparisonofsymptomaticvasospasmaftersurgicalclippingandendovascularcoiling
AT nobuyukifukui comparisonofsymptomaticvasospasmaftersurgicalclippingandendovascularcoiling
AT yoshihiroomura comparisonofsymptomaticvasospasmaftersurgicalclippingandendovascularcoiling
AT natsuhisasaki comparisonofsymptomaticvasospasmaftersurgicalclippingandendovascularcoiling
AT tomoakiakiyama comparisonofsymptomaticvasospasmaftersurgicalclippingandendovascularcoiling
AT tatsumarufukuda comparisonofsymptomaticvasospasmaftersurgicalclippingandendovascularcoiling
AT shinjikajiura comparisonofsymptomaticvasospasmaftersurgicalclippingandendovascularcoiling
AT masashishigeyasu comparisonofsymptomaticvasospasmaftersurgicalclippingandendovascularcoiling
AT kentoasakura comparisonofsymptomaticvasospasmaftersurgicalclippingandendovascularcoiling
AT ryohorii comparisonofsymptomaticvasospasmaftersurgicalclippingandendovascularcoiling
AT nobuyukisakai comparisonofsymptomaticvasospasmaftersurgicalclippingandendovascularcoiling